Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could significantly improve the effectiveness of peptide-based cancer vaccines, according to a study published in Advanced Functional Materials.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
